← Every company
Bristol-Myers Squibb Co SEC Filings
What Bristol-Myers Squibb Co has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BMY overview →Filings on file
145
since Oct 27, 2016
Warning signs
0
none filed
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Apr 14, 2025 | Tender offer SC TO-T | Read ↗ |
| Jan 25, 2024 | Tender offer SC TO-T | Read ↗ |
| Jun 17, 2022 | Tender offer SC TO-T | Read ↗ |
| Oct 19, 2020 | Tender offer SC TO-T | Read ↗ |
| May 20, 2020 | Merger vote or registration S-4 | Read ↗ |
| Feb 5, 2020 | Acquisition or sale completed 8-K/A | Read ↗ |
| Nov 22, 2019 | Acquisition or sale completedMaterial agreementNew debt 8-K | Read ↗ |
| Nov 20, 2019 | Executive or director changeAcquisition or sale completedMaterial agreementNew debt 8-K | Read ↗ |
| Feb 1, 2019 | Merger vote or registration S-4 | Read ↗ |
Source: Bristol-Myers Squibb Co's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BMY
Company overviewEverything on BMY in one place, with the price.Insider tradingWhat BMY's own officers and directors buy and sell.Who owns itEvery manager reporting a position in BMY.Funds holding itWhich funds and ETFs hold BMY, and how big a bet.LobbyingWhat BMY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BMY's account, and who they worked for.Federal contractsWhat federal agencies pay BMY.PatentsWhat BMY is filing at the patent office.